The association between the socioeconomic status and thyroid cancer prevalence; based on the Korean national health and nutrition examination survey 2010-2011

Journal of Korean Medical Science

Volumn 28, Issue 12, 2013, Pages 1734-1740

  Choi, Seong Woo ^a   Ryu, So Yeon ^a   Han, Mi Ah ^a   Park, Jong ^a  

^a Chosun University College of Medicine   (South Korea)

Author keywords

Social class; Thyroid neoplasms

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DEMOGRAPHY; DRINKING BEHAVIOR; ECONOMICS; FEMALE; HUMAN; INCOME; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION; PREVALENCE; RISK; RISK FACTOR; SEX DIFFERENCE; SOCIAL CLASS; SOCIOECONOMICS; SOUTH KOREA; STATISTICAL MODEL; THYROID TUMOR;

SOCIAL CLASS; THYROID NEOPLASMS;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; DEMOGRAPHY; FEMALE; HUMANS; INCOME; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; ODDS RATIO; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; THYROID NEOPLASMS;

EID: 84906531539     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.12.1734     Document Type: Article

References (34)

1. Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M, Guizard A, Tretarre B, Buemi AV, Arveux P, et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 2002; 38: 1762-8.
2. Verkooijen HM, Fioretta G, Pache JC, Franceschi S, Raymond L, Schubert H, Bouchardy C. Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 2003; 14: 13-7.
3. Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 2005; 62: 156-62.
4. Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 2004; 11: 1093-7.
5. Liu S, Semenciw R, Ugnat AM, Mao Y. Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer 2001; 85: 1335-9.
6. Burgess JR. Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid 2002; 12: 141-9.
7. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013; 45: 1-14.
8. International Agency for Research on Cancer. GLOBOCAN 2008. Available at http://globocan.iarc.fr [accessed on 21 August 2013].
9. Schneider AB, Ron E, Lubin J, Stovall M, Gierlowski TC. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 1993; 77: 362-9.
10. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, et al. Cancer incidence in atomic bomb survivors: part II: solid tumors, 1958-1987. Radiat Res 1994; 137: S17-67.
11. Franceschi S. Iodine intake and thyroid carcinoma: a potential risk factor. Exp Clin Endocrinol Diabetes 1998; 106: S38-44.
12. Goodman MT, Kolonel LN, Wilkens LR. The association of body size, reproductive factors and thyroid cancer. Br J Cancer 1992; 66: 1180-4.
13. Cote GJ, Wohllk N, Evans D, Goepfert H, Gagel RF. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Baillieres Clin Endocrinol Metab 1995; 9: 609-30.
14. Rossing MA, Cushing KL, Voigt LF, Wicklund KG, Daling JR. Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiology 2000; 11: 49-54.
15. Dal Maso L, La Vecchia C, Franceschi S, Preston-Martin S, Ron E, Levi F, Mack W, Mark SD, McTiernan A, Kolonel L, et al. A pooled analysis of thyroid cancer studies: V. anthropometric factors. Cancer Causes Control 2000; 11: 137-44.
16. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-7.
17. Rojeski MT, Gharib H. Nodular thyroid disease: evaluation and management. N Engl J Med 1985; 313: 428-36.
18. Ross DS. J Editorial: predicting thyroid malignancy. J Clin Endocrinol Metab 2006; 91: 4253-5.
19. Liebeskind A, Sikora AG, Komisar A, Slavit D, Fried K. Rates of malig nancy in incidentally discovered thyroid nodules evaluated with sonography and fine-needle aspiration. J Ultrasound Med 2005; 24: 629-34.
20. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009; 18: 784-91.
21. Fincham SM, Ugnat AM, Hill GB, Kreiger N, Mao Y. Is occupation a risk factor for thyroid cancer? Canadian Cancer Registries Epidemiology Research Group. J Occup Environ Med 2000; 42: 318-22.
22. Levi F, Franceschi S, Te VC, Negri E, Vecchia C. Descriptive epidemiology of thyroid cancer in the Swiss Canton of Vaud. J Cancer Res Clin Oncol 1990; 116: 639-47.
23. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control 2000; 11: 163-70.
24. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 2001; 93: 745-50.
25. Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 2008; 19: 585-93.
26. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev 2011; 12: 1657-63.
27. Kim JM, Kim HM, Jung BY, Park EC, Cho WH, Lee SG. The association between cancer incidence and family income: analysis of Korean National Health Insurance cancer registration data. Asian Pac J Cancer Prev 2012; 13: 1371-6.
28. Kim Y, Lee BK. Associations of blood lead, cadmium, and mercury with estimated glomerular filtration rate in the Korean general population: analysis of 2008-2010 Korean National Health and Nutrition Examination Survey data. Environ Res 2012; 118: 124-9.
29. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009; 20: 525-31.
30. Lee TJ, Kim S, Cho HJ, Lee JH. The incidence of thyroid cancer is affected by the characteristics of a healthcare system. J Korean Med Sci 2012; 27: 1491-8.
31. Newacheck PW, Hung YY, Park MJ, Brindis CD, Irwin CE Jr. Disparities in adolescent health and health care: does socioeconomic status matter? Health Serv Res 2003; 38: 1235-52.
32. Lazarus JH. Hyperthyroidism. Lancet 1997; 349: 339-43.
33. Zhang Y, Zhu Y, Risch HA. Changing incidence of thyroid cancer. JAMA 2006; 296: 1350.
34. Lee SH, Kim TY, Ryu JS, Gong G, Kim WB, Kim SC, Hong SJ, Shong YK. Trends analysis of characteristics of thyroid cancer patients in one medical center. J Korean Endocr Soc 2008; 23: 35-43.